Okamoto, A.; Asai, T.; Ryu, S.; Ando, H.; Maeda, N.; Dewa, T.; Oku, N.
Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. J. Clin. Med. 2016, 5, 10.
https://doi.org/10.3390/jcm5010010
AMA Style
Okamoto A, Asai T, Ryu S, Ando H, Maeda N, Dewa T, Oku N.
Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. Journal of Clinical Medicine. 2016; 5(1):10.
https://doi.org/10.3390/jcm5010010
Chicago/Turabian Style
Okamoto, Ayaka, Tomohiro Asai, Sho Ryu, Hidenori Ando, Noriyuki Maeda, Takehisa Dewa, and Naoto Oku.
2016. "Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow" Journal of Clinical Medicine 5, no. 1: 10.
https://doi.org/10.3390/jcm5010010
APA Style
Okamoto, A., Asai, T., Ryu, S., Ando, H., Maeda, N., Dewa, T., & Oku, N.
(2016). Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. Journal of Clinical Medicine, 5(1), 10.
https://doi.org/10.3390/jcm5010010